These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7593728)

  • 21. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.
    Orsel Donbak S; Turkçapar MH; Ozturk Kiliç EZ; Demirergi N; Akdemir A; Sirin A; Ozbay MH
    Acta Psychiatr Belg; 1995; 95(3):139-51. PubMed ID: 8525856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain.
    Civeira J; Cervera S; Giner J; Allen SR; Hellstern K; Malanowski H; Wirz R; Klar K
    Acta Psychiatr Scand Suppl; 1990; 360():48-9. PubMed ID: 2248070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicentre comparative trial of moclobemide, imipramine and placebo in major depressive disorder. UK Moclobemide Study Group.
    Int Clin Psychopharmacol; 1994; 9(2):109-13. PubMed ID: 8056992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the efficacy and tolerability of moclobemide and maprotiline in depressed patients treated by general practitioners.
    Gachoud JP; Dick P; Köhler M
    Clin Neuropharmacol; 1994; 17 Suppl 1():S29-37. PubMed ID: 7954482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moclobemide versus tranylcypromine in the treatment of depression.
    Rossel L; Moll E
    Acta Psychiatr Scand Suppl; 1990; 360():61-2. PubMed ID: 2248075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluoxetine versus moclobemide: cross-comparison between the time courses of improvement.
    Stassen HH; Angst J; Delini-Stula A
    Pharmacopsychiatry; 1999 Mar; 32(2):56-60. PubMed ID: 10333163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.
    Ucha Udabe R; Márquez CA; Traballi CA; Portes N
    Acta Psychiatr Scand Suppl; 1990; 360():54-6. PubMed ID: 2123367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.
    Hong CJ; Hu WH; Chen CC; Hsiao CC; Tsai SJ; Ruwe FJ
    J Clin Psychiatry; 2003 Aug; 64(8):921-6. PubMed ID: 12927007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression.
    Ramasubbu R
    J Psychiatry Neurosci; 1999 Jan; 24(1):45-50. PubMed ID: 9987207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moclobemide and fluoxetine for panic disorder. International Panic Disorder Study Group.
    Tiller JW; Bouwer C; Behnke K
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 1():S7-10. PubMed ID: 10361960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moclobemide and fluoxetine in atypical depression: a double-blind trial.
    Lonnqvist J; Sihvo S; Syvälahti E; Kiviruusu O
    J Affect Disord; 1994 Nov; 32(3):169-77. PubMed ID: 7852659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression.
    Costa e Silva J
    J Clin Psychiatry; 1998 Jul; 59(7):352-7. PubMed ID: 9714263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Moclobemide for anxiety disorders: a focus on moclobemide for panic disorder.
    Tiller JW; Bouwer C; Behnke K
    Int Clin Psychopharmacol; 1997 Oct; 12 Suppl 6():S27-30. PubMed ID: 9466172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moclobemide versus placebo in the treatment of depression: a multicentre study in Belgium.
    Botte L; Gilles C; Evrard JL; Mesters P; Wolfrum C; Berger M; Hellstern K; Ward J
    Acta Psychiatr Scand Suppl; 1990; 360():42. PubMed ID: 2248066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
    Fava M; Rosenbaum JF; Hoog SL; Tepner RG; Kopp JB; Nilsson ME
    J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of moclobemide on depressive symptoms and cognitive performance in a geriatric population: a controlled comparative study versus imipramine.
    Pancheri P; Delle Chiaie R; Donnini M; Seripa S; Gambino C; Vicario E; Trillo L
    Clin Neuropharmacol; 1994; 17 Suppl 1():S58-73. PubMed ID: 7954485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.
    Silverstone PH; Salinas E
    J Clin Psychiatry; 2001 Jul; 62(7):523-9. PubMed ID: 11488362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic features.
    Sheehan DV; Nemeroff CB; Thase ME; Entsuah R;
    Int Clin Psychopharmacol; 2009 Mar; 24(2):61-86. PubMed ID: 19238088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of moclobemide, amitriptyline and placebo in depression: a Canadian multicentre study.
    Bakish D; Bradwejn J; Nair N; McClure J; Remick R; Bulger L
    Psychopharmacology (Berl); 1992; 106 Suppl():S98-101. PubMed ID: 1546154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group.
    Versiani M; Amrein R; Stabl M
    Int Clin Psychopharmacol; 1997 Jul; 12(4):183-93. PubMed ID: 9347378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.